Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

October 30, 2018 Leave a comment 1,547 Views

AMPEL BioSolutions announced proof-of-principle for a multi-pronged approach to rank small molecules and biologics for safe, effective treatment of patients with Systemic Lupus Erythematosus (SLE) and...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Stelara

Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

LACE-seq – global profiling of RNA-binding protein target sites

Researchers publish first transcriptomic study of decompression sickness

Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture models

Bias in RNA-seq Library Preparation

Identifying differentially expressed circular RNAs associated with DNA methylation change

Single-cell RNA sequencing reveals how kidney cancer develops and responds to treatment

ppcseq – probabilistic outlier identification for RNA sequencing generalized linear models